Trials / Suspended
SuspendedNCT03726112
Spoton Trial Evaluating the Efficacy on BAlance Disorder sYmptoms (STEADY)
A Randomized, Double Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SpotOn Specs for the Treatment of Chronic Dizziness & Imbalance
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- SpotOn Therapeutics Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Double Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SpotOn specs for the Treatment of Chronic Dizziness \& Imbalance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SpotOn Specs | SpotOn Balance glasses consists of unique visual stimuli (SpotOn's Neuro Balance Active Spots) applied to specific zones in the peripheral visual field |
| DEVICE | Sham Specs | Sham device |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2019-12-01
- Completion
- 2020-04-01
- First posted
- 2018-10-31
- Last updated
- 2019-05-08
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03726112. Inclusion in this directory is not an endorsement.